HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Signal transduction molecules in gliomas of all grades.

AbstractPURPOSE:
To interrogate grade II, III, and IV gliomas and characterize the critical effectors within the PI3-kinase pathway upstream and downstream of mTOR. Experimental design Tissues from 87 patients who were treated at UCSF between 1990 and 2004 were analyzed. Twenty-eight grade II, 17 grade III glioma, 26 grade IV gliomas, and 16 non-tumor brain specimens were analyzed. Protein levels were assessed by immunoblots; RNA levels were determined by polymerase chain reaction amplification. To address the multiple comparisons, first an overall analysis was done comparing the four groups using Spearman's Correlation Coefficient. Only if this analysis was statistically significant were individual pairwise comparisons done.
RESULTS:
Multiple comparison analyses revealed a significant correlation with grade for all variables examined, except phosphorylated-S6. Expression of phosphorylated-4E-BP1, phosphorylated-PKB/Akt, PTEN, TSC1, and TSC2 correlated with grade (P < 0.01 for all). We extended our analyses to ask whether decreases in TSC proteins levels were due to changes in mRNA levels, or due to changes in post-transcriptional alterations. We found significantly lower levels of TSC1 and TSC2 mRNA in GBMs than in grade II gliomas or non-tumor brain (P < 0.01).
CONCLUSIONS:
Expression levels of critical signaling molecules upstream and downstream of mTOR differ between non-tumor brain and gliomas of any grade. The single variable whose expression did not differ between non-tumor brain and gliomas was phosphorylated-S6, suggesting that other protein kinases, in addition to mTOR, contribute significantly to S6 phosphorylation. mTOR provides a rational therapeutic target in gliomas of all grades, and clinical benefit may emerge as mTOR inhibitors are combined with additional agents.
AuthorsRalph P Ermoian, Tania Kaprealian, Kathleen R Lamborn, Xiaodong Yang, Nannette Jelluma, Nils D Arvold, Ruth Zeidman, Mitchel S Berger, David Stokoe, Daphne A Haas-Kogan
JournalJournal of neuro-oncology (J Neurooncol) Vol. 91 Issue 1 Pg. 19-26 (Jan 2009) ISSN: 0167-594X [Print] United States
PMID18759130 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Intracellular Signaling Peptides and Proteins
  • Protein Kinases
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
Topics
  • Brain Neoplasms (diagnosis, genetics, metabolism)
  • Gene Expression Regulation, Neoplastic (genetics)
  • Glioma (diagnosis, genetics, metabolism)
  • Humans
  • Intracellular Signaling Peptides and Proteins (genetics, metabolism)
  • Phosphatidylinositol 3-Kinases (genetics, metabolism)
  • Protein Kinases (genetics, metabolism)
  • Retrospective Studies
  • Signal Transduction (genetics)
  • Statistics, Nonparametric
  • TOR Serine-Threonine Kinases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: